Navigation Links
3SBio and Isotechnika Pharma Announce Strategic Partnership to Develop and Commercialize Voclosporin in China
Date:8/24/2010

der the ticker symbol "SSRX". Please see http://www.3SBio.com for more information.

About Isotechnika Pharma Inc.

Isotechnika Pharma Inc. is a biopharmaceutical company focused on the discovery and development of immunomodulating therapeutics that are designed to offer advantages over other currently available treatments.

Voclosporin, Isotechnika Pharma's lead drug candidate, is a next generation calcineurin inhibitor. It has completed a Phase 2b study for the prevention of kidney rejection following transplantation and a Phase 3 European/Canadian trial for the treatment of moderate to severe psoriasis. Isotechnika Pharma continues to explore additional licensing opportunities for other key markets including Europe, North America and the other regions of Asia not currently licensed.

Our partner, Lux Biosciences, filed dossiers for approval of voclosporin in the U.S. and in Europe for the treatment of non-infectious uveitis. Currently Lux is awaiting the decision from Europe and is preparing to commence an additional Phase 3 pivotal trial for US approval purposes.

Isotechnika Pharma Inc. is a publicly traded company on the Toronto Stock Exchange under the symbol "ISA". More information on Isotechnika Pharma can be found at http://www.isotechnika.com or http://www.SEDAR.com .

Isotechnika Pharma will hold its Annual General & Special Meeting on September 9, 2010 at 2pm MST at the Delta Edmonton South.

For more information, please contact: Investor contacts: Bo Tan Chief Financial Officer 3SBio Inc. Tel: +86-24-2581-1820 Email: ir@3SBio.com Tom Folinsbee Director of Investor Relations 3SBio Inc. Tel: +852-8191-6991 Email: ir@3SBio.com
'/>"/>

SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. 3SBio Inc. Announces Results of Annual General Meeting
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/p37spr/north_america ) has announced ... MRI Market - Growth, Trends And Forecasts (2014 - ... key players in the industry are GE , Hitachi ... Medical Systems MRI is a ... its higher sensitivity and use of non-ionizing radiations. Open ...
(Date:5/29/2015)... and SPARTANBURG, South Carolina ... Guardian Research Network and Molecular Health have announced a ... molecular diagnostic decision support to the majority of cancer ... Research Network will collaborate with Molecular Health to harness ... to identify cohorts from hundreds of thousands of patients ...
(Date:5/29/2015)... 2015  Haemonetics Corporation (NYSE: HAE ) announced ... will present at the JMP Securities Life Sciences Conference ... 23 rd , 2015 at 11:30am Eastern time.  ... live via webcast at: http://wsw.com/webcast/jmp27/hae ... is a global healthcare company dedicated to providing innovative ...
Breaking Medicine Technology:North America Open System MRI Market 2014-2019 with GE, Hitachi Medical, Philips Healthcare, Siemens Healthcare and Toshiba Medical Dominating 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 4
... FRANKLIN LAKES, N.J., Sept. 8 BD (Becton, Dickinson and ... company, announced today that it will present at the 2010 ... 1:35 p.m. EDT. A live webcast of BD,s ... www.bd.com/investors and will be available for replay through ...
... Sept. 8 STAAR Surgical Company (Nasdaq: ... of phakic intraocular lenses, today announced that the Visian ... than 40 presentations by leading ophthalmologists at meetings prior ... of Cataract and Refractive Surgeons (ESCRS) held in Paris, ...
Cached Medicine Technology:STAAR Surgical Launches New Visian ICL™ Product Line Extensions at ESCRS 2STAAR Surgical Launches New Visian ICL™ Product Line Extensions at ESCRS 3STAAR Surgical Launches New Visian ICL™ Product Line Extensions at ESCRS 4STAAR Surgical Launches New Visian ICL™ Product Line Extensions at ESCRS 5STAAR Surgical Launches New Visian ICL™ Product Line Extensions at ESCRS 6
(Date:5/29/2015)... May 29, 2015 The campaign focuses ... as a number of specific concerns within, including the ... and mental health in the workplace. We are encouraged ... The campaign also brings special focus to people living ... speak up and seek help from healthcare professionals and ...
(Date:5/29/2015)... 29, 2015 Shaila Jiwa, a physiotherapist ... has recently stated in a new announcement that patients ... Continence is commonly seen as a tabooed topic to ... Expert physiotherapists like Shaila Jiwa try to encourage people ... , Incontinence is a condition that can be classified ...
(Date:5/29/2015)... The report “Muscle Spasm – ... the therapeutic development for Muscle Spasm. Spasms may ... body, leading to many different symptoms and presentations. ... targets and MOAs to produce first-in-class and best-in-class ... of Axillary Hyperhidrosis with 19 market data tables ...
(Date:5/29/2015)... May 29, 2015 The Global ... in-depth study on the current state of the ... provides key statistics on the state of the ... and direction for companies and individuals interested in ... of the industry including definitions, classifications, applications and ...
(Date:5/29/2015)... The Croatia Cosmetic Dentistry Center - ... on what modern dentistry options are available today. The ... to revolutionize the perception of a dental practice — ... Spa. , The top dental provider is partnered ... tourism agencies and led by world-renowned experts, Dr. ...
Breaking Medicine News(10 mins):Health News:Mediaplanet Brings Activism to Those Living with Mental Illness in Bew “Mental Health Awareness” Campaign 2Health News:Patients of Urinary Incontinence Should Not "Hide And Suffer," States Physiotherapist from Burnaby Physiotherapy Clinic 2Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Allopurinol Industry (Global, China) 2015 Research Analysis and 2020 Forecasts 2Health News:Croatian Cosmetic Dentistry Providers New Approach to Revolutionize Cosmetic Dentistry 2Health News:Croatian Cosmetic Dentistry Providers New Approach to Revolutionize Cosmetic Dentistry 3
... HighPoint Solutions LLC,a premier provider of business-driven ... develop an Incentive Compensation Plan for a new ... review.,With the project,s completion targeted for late summer ... motivate the field sales force and ensure the,alignment ...
... House expected to vote on bill this evening. , ... Alexandria, Va. ... Drug Stores (NACDS), endorsed a House bill, H.R.6331, the Medicare ... several provisions of critical importance to chain pharmacies and the patients they ...
... largest health community on the web, and HealthCare.com partner to ... , ... San Francisco, CA and Miami, ... the largest health community on the web, and HealthCare.com, Inc. ...
... shows increase in Social Security Disability Insurance recipients; time-intensive process of ... says Allsup , ... Belleville, Ill. (Vocus) June 25, ... Disability Insurance (SSDI) benefits continued to grow in 2007. This ...
... new classified assessment that explores how climate change could ... causing political instability, mass movements of refugees, terrorism, or ... The House Intelligence Committee is scheduled to be briefed ... While the assessment itself is ...
... are the workhorses of our cells. They help to digest ... and literally shape our body from top to toe. Proteins ... of enzymes, which are important in the creation of anything ... possibilities are virtually without limit. , To take advantage ...
Cached Medicine News:Health News:HighPoint Solutions Develops Novel Incentive Compensation Plan for New Benign Prostatic Hyperplasia (BPH) Product 2Health News:NACDS Praises House Legislation to Delay Medicaid Cuts, Aid Pharmacies in Treating Patients 2Health News:MedHelp Launches Healthcare Provider Search Powered by HealthCare.com 2Health News:MedHelp Launches Healthcare Provider Search Powered by HealthCare.com 3Health News:SSDI Recipients Ask: When Do I Get My Benefits? 2Health News:SSDI Recipients Ask: When Do I Get My Benefits? 3Health News:Climate change may challenge national security, classified report warns 2Health News:Climate change may challenge national security, classified report warns 3Health News:1 step closer to green chemistry and improved pharmaceuticals 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: